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During the past decade, disclosure of conflicts of interest
(COIs) has been considered the key to ensure the credibility
of the scientific process [1, 2]. Biases in design, analysis, and
interpretation of studies may rise when authors or sponsors
have entrusted interests. Therefore, COIs should be made
clear to the readers to facilitate their own judgement and
interpretation of their relevance and potential implications.
Authors are responsible for fully disclosing potential COIs.
Failure to do so will upset the confidence of the public, health
professionals and scientists in the peer-reviewed medical
literature [3]. Efforts to improve transparency and protect the
integrity of research, including specific recommendations and
guidelines to disclose COIs, have been proposed by many
organisations [4, 5]. However, ensuring adequate reporting
of all sources of financial support is becoming increasingly
challenging for editors as a result of the growing complexity
of funding mechanisms. Furthermore, journals have different
policies about COI disclosure which can cause confusion as
the same author may report different information in different
journalswhich,inturn, might jeopardise the confidenceof the
readers. In addition, publication of large industry-supported
trialsmaygeneratemanycitationsandjournalincomethrough
reprint sales and thereby be a source of COIs for journals.
To illustrate this,Andres Lundh et al. [6]fromCopenhagen,
Denmark, evaluated six major medical journals (Annals
of Internal Medicine, Archives of Internal Medicine, BMJ,
JAMA, The Lancet, and New England Journal of Medicine
[NEJM]) in order to investigate industry-supported trials’
influence on journal impact factors and revenue. The
proportion of trials with sole industry support varied between
journals from 7 % in BMJ to 32 % in NEJM in 2005–2006.
Industry-supportedtrialsweremorefrequentlycitedthantrials
with other types of support, and omitting them from the
impact factor calculation decreased journal impact factors.
The decrease varied considerably between journals, with
1 % for BMJ to 15 % for NEJM in 2007. For the two journals
disclosing data, income from the sales of reprints contributed
to 3 % and 41 % of the total income for BMJ and The Lancet
in 2005–2006 (NEJM and JAMA did not respond!). The
authorsconcludedthatpublicationofindustry-supportedtrials
was associated with an increase in journal impact factors. It
was suggested that journals disclose financial information in
the same way that they require it from their authors, so that
readers can assess the potential effect of different types of
papers on journals’ revenue and impact.
According to the International Committee of Medical
Journal Editors (ICMJE), COIs exist when an author (or
the author’s institution), reviewer, or editor has financial
or personal relationships that inappropriately influence
(bias) his or her actions. Four main areas can be discerned:
1) authors’ associations with entities that supported the
submitted manuscript, 2) associations with commercial
entities with potential interest in the general area of the
manuscript, 3) financial association of their spouse (!) and
children, and 4) finally, non-financial associations potentially
relevant to the submitted manuscript. To prevent ambiguity,
authors should be explicitly asked to state whether COIs exist
or do not exist. Editors should publish this information if they
believe that it is important in judging the manuscript. To
overcome these problems, the ICMJE proposed the use
of a common vehicle to report COIs and, in October
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DOI 10.1007/s12471-012-0287-52009, launched an electronic ‘uniform’ format for COI
disclosure [7]. The reporting form has been made available
at www.icmje.org/coi_disclosure.pdf.
Several years ago the European Society of Cardiology
(ESC) launched the Editors’ Network with the purpose to
promote the dissemination and implementation of high-
quality editorial standards among ESC National Societies
Cardiovascular Journals (NSCJ) [8, 9]. To determine
the status of COIs and disclosure requirements among
ESC NSCJ, a web-based, comprehensive, structured, and
standardised questionnaire was specifically devised and
sent out in June 2010. A total of 46 national journals
answered the survey. Of these, 35 belong to the ESC
NSCJ and 11 to journals of Affiliated Cardiac Societies.
This represents a response of 83 % (35/42) of NSCJ and
58 % (11/19) for Affiliated Cardiac Societies.
In the current issue of the Netherlands Heart Journal the
results of the survey are presented [10]. These data will be
more or less simultaneously published this year in all 46
national journals [11]. The most important results are the
following. Only 18 % of the journals have a specific policy
on editors’ COIs, 25 % of the journals have policies for
reviewers’ COIs, and 44 % have a specific policy on
authors’ COIs. In most cases, emphasis was only made on
financial COIs and on COIs directly related to the submitted
work. Few journals provided definitions or examples of
COIs. In most cases where COIs were requested, this policy
affected all kinds of submitted articles. Written attestation
by the authors was widely requested. Policies to deal with
authors who fail to disclose COIs were hardly present. In
most journals, the editors decided when authors’ COIs
should be published but, in some journals, this information
was systematically published. In more than half of the
journals(54%),reviewers wereaskedtodecline theinvitation
to review if potential COIs existed. Only one-third of the
editorswerefamiliarwiththenew‘UniformDisclosureForm’
ICMJE initiative when they received the survey invitation.
However, 90 % of the editors considered the ICMJE COI
proposal of potential value to their particular journals and
most of them declared that they were willing to implement it
within a relatively short period of time.
To summarise, this survey reports the issue of ESC NSCJ
policies on COI and disclosure requirements from a global
and didactic perspective and provides new insights into
current policies and practices among ESC NSCJ. It clearly
confirms that this topic is only poorly and not uniformly
dealt with by most of the national journals. In the near
future, progressive steps should be taken to guarantee a
systematic approach to these COI-related editorial issues.
Fortunately, the ESC has recently defined a general policy for
COIs [12]. In this document recommendations are given on
how to minimise bias in scientific communications and
continuing medical education (CME) and how to ensure
proper ethical standards and transparency in relations
between the medical profession and industry. It goes
without saying that our journal will implement these
recommendations in its editorial policies!
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